Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.3 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.042 | 0.3 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |